Post-market surveillance through the FDAs Adverse Event Reporting System (FAERS) database documented hundreds of gastroparesis reports within the first years of approval, establishing a clear safety signal that warranted immediate label updates
This tailored guidance can boost confidence in handling the injection
In the event the test results indicate any abnormalities for which medical treatment may be necessary, you will be referred back to your own primary physician for follow up
Check our detailed guide on drinking alcohol on semaglutide for specific recommendations
[1] Important safety considerations include the risk of hypoglycaemia when combined with insulin or sulfonylureas, potential dehydration and acute kidney injury with severe gastrointestinal symptoms, and for semaglutide specifically, possible worsening of diabetic retinopathy in those with pre-existing disease
If you start a compounded semaglutide program through Direct Meds and the FDA cracks down on compounding, you may need to transition to brand-name options at significantly higher cost or find alternative weight management strategies
